Brought to you by 
Re-branded, Lifecode raises $20.5mm through Series A round
12 May 2015
Executive Summary
Lifecode Inc. (molecular diagnostics) raised $20.5mm in Series A funding from Sequoia Capital, the Mayo Clinic, and Mayo Ventures. The company was formerly known as Silicon Valley Biosystems, but changed its name earlier this year.
Deal Industry
- In Vitro Diagnostics
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Re-branded, Lifecode raises $20.5mm through Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice